| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -92,687 | -100.0% | -0.02% | – |
| Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -116,324 | -100.0% | -0.17% | – | |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -2,244,378 | -100.0% | -0.33% | – |
| Exit | APOGEE THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.62% | – | |
| Exit | RAYZEBIO INC | $0 | – | -288,911 | -100.0% | -0.75% | – | |
| Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -1,575,000 | -100.0% | -0.96% | – | |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -739,661 | -100.0% | -1.06% | – |
| Exit | THIRD HARMONIC BIO INC | $0 | – | -1,700,000 | -100.0% | -1.27% | – | |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -1,400,000 | -100.0% | -1.49% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -957,509 | -100.0% | -1.62% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -500,000 | -100.0% | -1.74% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -10,000,000 | -100.0% | -1.75% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -1,325,000 | -100.0% | -1.77% | – |
| CELC | Exit | CELCUITY INC | $0 | – | -1,694,141 | -100.0% | -1.81% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -706,665 | -100.0% | -2.27% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -775,000 | -100.0% | -2.44% | – |
| Exit | SOLENO THERAPEUTICS INC | $0 | – | -887,500 | -100.0% | -3.06% | – | |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -565,000 | -100.0% | -3.34% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -2,200,000 | -100.0% | -3.94% | – |
| Exit | NUVALENT INC | $0 | – | -828,778 | -100.0% | -4.45% | – | |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -1,000,000 | -100.0% | -4.49% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -2,525,753 | -100.0% | -4.49% | – |
| Exit | ENLIVEN THERAPEUTICS INC | $0 | – | -2,901,816 | -100.0% | -4.63% | – | |
| AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -3,518,556 | -100.0% | -4.73% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -2,075,000 | -100.0% | -5.56% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -5,566,026 | -100.0% | -6.34% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -1,100,000 | -100.0% | -6.56% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -1,845,000 | -100.0% | -7.37% | – |
| VERA | Exit | VERA THERAPEUTICS INCcl a | $0 | – | -5,450,000 | -100.0% | -8.73% | – |
| MRUS | Exit | MERUS N V | $0 | – | -4,428,072 | -100.0% | -12.20% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 12 | Q3 2023 | 10.3% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.4% |
| VIRIDIAN THERAPEUTICS INC | 11 | Q3 2023 | 8.9% |
| CYMABAY THERAPEUTICS INC | 11 | Q2 2023 | 5.4% |
| KURA ONCOLOGY INC | 11 | Q3 2023 | 7.1% |
| CELLDEX THERAPEUTICS INC NEW | 11 | Q3 2023 | 3.8% |
| ACLARIS THERAPEUTICS INC | 10 | Q1 2023 | 10.4% |
| CELCUITY INC | 10 | Q3 2023 | 7.3% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q2 2023 | 2.2% |
| MERUS N V | 9 | Q3 2023 | 12.5% |
View COMMODORE CAPITAL LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | April 27, 2023 | 31,181,983 | 8.1% |
| BELLUS Health Inc. | March 30, 2023 | 6,579,359 | 5.2% |
| IMARA Inc. | February 21, 2023 | 2,840,754 | 10.8% |
| Karyopharm Therapeutics Inc. | February 14, 2023 | 1,935,609 | 1.7% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Satsuma Pharmaceuticals, Inc.Sold out | November 16, 2022 | 0 | 0.0% |
| GENOCEA BIOSCIENCES, INC. | February 14, 2022 | 3,079,756 | 5.4% |
View COMMODORE CAPITAL LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-19 |
| SC 13G | 2024-03-21 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View COMMODORE CAPITAL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.